Coronary artery disease (CAD) is a major cause of morbidity and mortality in human worldwide. Recent interest has focused on chronic infectious diseases like periodontal infection as potential contributors to CAD since traditional risk factors like hypercholesterolemia, smoking and hypertension fail to fully explain the incidence of CAD in populations. Epidemiological studies indicate that individuals with periodontal infection are 30 to 100% more likely to have CAD; however, it remains possible that confounding factors account for these observations and mechanistic studies to explain this connection are lacking. Periodontal disease is associated with a state of systemic inflammation, and a likely target for circulating cytokines and oral pathogens is the vascular endothelium, which plays a central role in the regulation of vascular homeostasis. Activation of endothelial cells by inflammatory cytokines promotes a pro-atherogenic phenotype with increased expression of inflammatory factors and loss of the anti-thrombotic, growth inhibitory, and vasodilator properties of the endothelium. These changes occur early in the development of atherosclerosis and contribute to the pathogenesis and clinical expression of disease. The purpose of this application is to test the hypothesis that the host inflammatory response plays a primary role in infection-aggravated atherosclerosis and investigate the specific signaling mechanisms that account for this process.
The Specific Aims of this application are:
Aim 1. To determine the relative importance of systemic inflammation versus direct bacterial invasion of the arterial wall for atherosclerotic lesion formation.
Aim 2 : To determine whether inhibition of Toll-like Receptor 2 (TLR2) and IL-1 receptor pathways limits atherogenesis following bacterial challenge.
Aim 3 : To determine whether activation of TLR2 and IL-1 receptor pathways aggravate atherosclerotic plaque formation.
Aim 4 : To determine whether a mouse model of bacterial periodontitis exacerbates atherosclerosis. The proposed studies will provide mechanistic insights into how Porphyromonas gingivalis contributes to atherosclerosis formation and progression. The long-term goal of this application is to develop therapeutic strategies aimed at controlling the deleterious effects of the inflammatory response in atherosclerosis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL076801-03
Application #
7172619
Study Section
Oral, Dental and Craniofacial Sciences Study Section (ODCS)
Program Officer
Tolunay, Eser
Project Start
2005-01-01
Project End
2008-12-31
Budget Start
2007-01-17
Budget End
2007-12-31
Support Year
3
Fiscal Year
2007
Total Cost
$382,828
Indirect Cost
Name
Boston University
Department
Dentistry
Type
Schools of Dentistry
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02118
Libby, Peter; Loscalzo, Joseph; Ridker, Paul M et al. (2018) Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. J Am Coll Cardiol 72:2071-2081
Cai, Bin; Panek, James S; Amar, Salomon (2018) Kava analogues as agents for treatment of periodontal diseases: Synthesis and initial biological evaluation. Bioorg Med Chem Lett 28:2667-2669
Alshammari, Abdulsalam; Patel, Jayesh; Al-Hashemi, Jacob et al. (2017) Kava-241 reduced periodontal destruction in a collagen antibody primed Porphyromonas gingivalis model of periodontitis. J Clin Periodontol 44:1123-1132
Huck, Olivier; Al-Hashemi, Jacob; Poidevin, Laetitia et al. (2017) Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection. Infect Immun 85:
Amar, S; Engelke, M (2015) Periodontal innate immune mechanisms relevant to atherosclerosis. Mol Oral Microbiol 30:171-85
Yuan, Huaiping; Zelkha, Sami; Zelka, Sami et al. (2013) Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss. Proc Natl Acad Sci U S A 110:E5059-68
Zelkha, Sami A; Freilich, Robert W; Amar, Salomon (2010) Periodontal innate immune mechanisms relevant to atherosclerosis and obesity. Periodontol 2000 54:207-21
Mazumdar, Varun; Snitkin, Evan S; Amar, Salomon et al. (2009) Metabolic network model of a human oral pathogen. J Bacteriol 191:74-90
Amar, Salomon; Wu, Shou-chieh; Madan, Monika (2009) Is Porphyromonas gingivalis cell invasion required for atherogenesis? Pharmacotherapeutic implications. J Immunol 182:1584-92
Madan, Monika; Amar, Salomon (2008) Toll-like receptor-2 mediates diet and/or pathogen associated atherosclerosis: proteomic findings. PLoS One 3:e3204

Showing the most recent 10 out of 18 publications